ADAM19 and central nervous system cancer: Reduced m6 A levels in ADAM19 mRNA (Cui et al. 2017) and in FOXM1 (Zhang et al. 2017) promote glioma stem cell proliferation and self‐renewal and ultimately lead to tumorigenesis.